Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Pollard

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
British Journal of Pharmacology|February 17, 2015
Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channelR Mannikko, M H Bridgland-Taylor, H Pye, et al.
British Journal of Pharmacology|August 14, 2009
Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channelRoope Männikkö, G Overend, C Perrey, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 27, 2011
An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessmentM R Davies, H B Mistry, L Hussein, et al.
Journal of Pharmacological and Toxicological Methods|November 6, 2007
Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorksA R Harmer, N Abi-Gerges, A Easter, et al.
British Journal of Pharmacology|January 1, 1995
Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPaseB E Crack, C E Pollard, M W Beukers, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 9, 2018
A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisationS Y A Cheung, J Parkinson, U Wählby-Hamrén, et al.
Journal of Pharmacological and Toxicological Methods|March 28, 2006
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HTM H Bridgland-Taylor, A C Hargreaves, A Easter, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
British Journal of Pharmacology|February 17, 2015
Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channelR Mannikko, M H Bridgland-Taylor, H Pye, et al.
British Journal of Pharmacology|August 14, 2009
Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channelRoope Männikkö, G Overend, C Perrey, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 27, 2011
An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessmentM R Davies, H B Mistry, L Hussein, et al.
Journal of Pharmacological and Toxicological Methods|November 6, 2007
Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorksA R Harmer, N Abi-Gerges, A Easter, et al.
British Journal of Pharmacology|January 1, 1995
Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPaseB E Crack, C E Pollard, M W Beukers, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 9, 2018
A tutorial on model informed approaches to cardiovascular safety with focus on cardiac repolarisationS Y A Cheung, J Parkinson, U Wählby-Hamrén, et al.
Journal of Pharmacological and Toxicological Methods|March 28, 2006
Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HTM H Bridgland-Taylor, A C Hargreaves, A Easter, et al.
Pageof 3